연구성과로 돌아가기

2024 연구자 정보 (466 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Haleema, Bibi
(Haleema, B) ⓘ 		제1저자 Agr Res Inst ARI, Floriculture Sect, Tarnab 25120, Pakistan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Comparative Effects of Calcium, Boron, and Zinc Inhibiting Physiological Disorders, Improving Yield and Quality of Solanum lycopersicum ⓘ SCIE ⓘ 18.2 BIOLOGY ⓘ haleema_12@yahoo.co.in;dr.syedtanveershah@hu.edu.pk;abdulbasit97_lily@knu.ac.kr;wafaahikal@gmail.com;marifkhan75@aup.edu.pk;waleedkhan.my@gmail.com;shussein272@yahoo.com;mudauf@ukzn.ac.za; ⓘ
Ham, Hyeonjung
(Ham, H) ⓘ 		Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] The clinical course of hospitalized COVID-19 patients and aggravation risk prediction models: a retrospective, multi-center Korean cohort study ⓘ SCIE ⓘ 18.2 MEDICINE, GENERAL & INTERNAL ⓘ ksw2kms@knu.ac.kr;tspark@stats.snu.ac.kr; ⓘ
Im, Seock-Ah
(Im, SA) ⓘ 		Seoul Natl Univ, Seoul Natl Univ Hosp, Canc Res Inst, Coll Med, Seoul, South Korea
Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea
Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea ⓘ 		J-5620-2012
Im, Seock-Ah ⓘ
ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
[JCR상위 0.3] Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial
[JCR상위 1.7] A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.
[JCR상위 0.3] Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024)
[JCR상위 27.1] A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) ⓘ 		SCIE ⓘ 0.3 OBSTETRICS & GYNECOLOGY;ONCOLOGY
BIOCHEMISTRY & MOLECULAR BIOLOGY;CELL BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL
ONCOLOGY ⓘ 		tsurutaj@med.showa-u.ac.jp;
meng.li7@pfizer.com;patricia.lorusso@yale.edu;
oncolee@ewha.ac.kr;yhparkhmo@skku.edu; ⓘ
Jo, Uiree
(Jo, U) ⓘ 		Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Kanemitsu, Shuichi
(Kanemitsu, S) ⓘ 		Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Kashiwaba, Masahiro
(Kashiwaba, M) ⓘ 		Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Kawano, Junko
(Kawano, J) ⓘ 		Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Kim, Dai Woo
(Kim, DW) ⓘ 		Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, Daegu 41944, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Case report: Management of recurrent pupillary optic capture with sutureless surgical technique using 7-0 polypropylene flange
[JCR상위 8.5] Real-time in vivo monitoring of intraocular pressure distribution in the anterior chamber and vitreous chamber for diagnosis of glaucoma ⓘ 		SCIE ⓘ 8.5 MEDICINE, GENERAL & INTERNAL
MULTIDISCIPLINARY SCIENCES ⓘ 		doojr@hanmail.net;
jang-ung@yonsei.ac.kr;proector97@gmail.com; ⓘ
Kuboniwa, Masae
(Kuboniwa, M) ⓘ 		Osaka Univ, Dept Prevent Dent, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka, Japan ⓘ
ⓘ 		0000-0002-3332-2431
Kuboniwa, Masae ⓘ 		[JCR상위 18.2] Effect of the oral examinations in the national health screening program on preventive oral health care and treatments: a 19-year follow-up study ⓘ SCIE ⓘ 18.2 DENTISTRY, ORAL SURGERY & MEDICINE ⓘ cyh1001@knu.ac.kr; ⓘ
Lee, Chanhee
(Lee, C) ⓘ 		Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] The clinical course of hospitalized COVID-19 patients and aggravation risk prediction models: a retrospective, multi-center Korean cohort study ⓘ SCIE ⓘ 18.2 MEDICINE, GENERAL & INTERNAL ⓘ ksw2kms@knu.ac.kr;tspark@stats.snu.ac.kr; ⓘ
Lee, Keun Seok
(Lee, KS) ⓘ 		Natl Canc Ctr, Gyeonggi Do, South Korea
Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
[JCR상위 1.7] A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.
[JCR상위 27.1] A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) ⓘ 		SCIE ⓘ 1.7 OBSTETRICS & GYNECOLOGY;ONCOLOGY
ONCOLOGY ⓘ 		tsurutaj@med.showa-u.ac.jp;
oncolee@ewha.ac.kr;yhparkhmo@skku.edu; ⓘ
Lee, Sae Byul
(Lee, SB) ⓘ 		Univ Ulsan, Coll Med, Dept Surg, Div Breast Surg,Asan Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer
[JCR상위 1.7] Long-term oncologic outcome of breast-conserving surgery in breast cancer with BRCA 1/2 mutation (ON-BRCA II, KoREa-BSG 06) ⓘ 		SCIE ⓘ 1.7 OBSTETRICS & GYNECOLOGY;ONCOLOGY
ONCOLOGY ⓘ 		mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Lee, Seungyeoun
(Lee, S) ⓘ 		Sejong Univ, Dept Math & Stat, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] The clinical course of hospitalized COVID-19 patients and aggravation risk prediction models: a retrospective, multi-center Korean cohort study ⓘ SCIE ⓘ 18.2 MEDICINE, GENERAL & INTERNAL ⓘ ksw2kms@knu.ac.kr;tspark@stats.snu.ac.kr; ⓘ
Lee, Young-Won
(Lee, YW) ⓘ 		Univ Ulsan, Coll Med, Dept Surg, Div Breast Surg,Asan Med Ctr, Seoul, South Korea ⓘ KEH-3755-2024
Lee, Youngwon ⓘ 		0000-0002-2862-4814
i, yeong-won ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Li, Wei
(Li, W) ⓘ 		First Hosp Jilin Univ, Jilin, Peoples R China
Hainan Med Univ, Neurol, Haikou, Hainan, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
[JCR상위 7.2] Antithrombotic regimen in emergent carotid stenting for acute ischemic stroke due to tandem occlusion: a meta-analysis of aggregate data ⓘ 		SCIE ⓘ 7.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY
NEUROIMAGING;SURGERY ⓘ 		tsurutaj@med.showa-u.ac.jp; ⓘ
페이지 이동: